Harbor Investment Advisory’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
GWM
IFG
SIS
FFA
GI
AAG
BTC
Harbor Investment Advisory's PJP Position: Q3 2026 in Review
Harbor Investment Advisory held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 150 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.
Harbor Investment Advisory first reported a position in PJP in Q4 2019 and has held it in 28 quarters since. 8 funds tracked by Wall St. Rank hold PJP as of Q3 2026.
- Harbor Investment Advisory held 150 shares of Invesco Pharmaceuticals ETF worth $18.5K as of Q3 2026.
- Harbor Investment Advisory left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q3 2026, its #1002 holding.
- Harbor Investment Advisory first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and has held it in 28 quarters since.
- 8 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.
Based on Harbor Investment Advisory's 13F filing for Q3 2026, filed 13 Oct 2026.